# Ultra Low Dose CT for CACS and AC of SPECT

Study · id `cardio:ct-nct02458352` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02458352](<https://clinicaltrials.gov/study/NCT02458352>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02458352

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 105 participants.

## Technical summary

Registry record NCT02458352. Allocation not applicable; no masking; primary purpose diagnostic. Start 2015-11 (registry gives no type); primary completion 2016-10 (actual). Results posted on 2019-10-18.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 105 participants (enrolled count; ClinicalTrials.gov record NCT02458352, source copy `cardio:ctgov-nct02458352-2019-10-18`, retrieved 2026-10-26)
- Start date: 2015-11 (registry gives no type) (ClinicalTrials.gov record NCT02458352, source copy `cardio:ctgov-nct02458352-2019-10-18`, retrieved 2026-10-26)
- Primary completion: 2016-10 (actual) (ClinicalTrials.gov record NCT02458352, source copy `cardio:ctgov-nct02458352-2019-10-18`, retrieved 2026-10-26)
- Completion: 2016-10 (actual) (ClinicalTrials.gov record NCT02458352, source copy `cardio:ctgov-nct02458352-2019-10-18`, retrieved 2026-10-26)
- Results first posted: 2019-10-18 (ClinicalTrials.gov record NCT02458352, source copy `cardio:ctgov-nct02458352-2019-10-18`, retrieved 2026-10-26)
- Countries: Switzerland (ClinicalTrials.gov record NCT02458352, source copy `cardio:ctgov-nct02458352-2019-10-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02458352-2019-10-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Ultra Low Dose CT for CACS and AC of SPECT
- Condition: Coronary Artery Disease
- Intervention (Device): Ultra low dose non-contrast enhanced CT
- Intervention (Device): Standard dose non-contrast enhanced CT
- Lead sponsor: University of Zurich
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: University of Zurich (`cardio:org-university-of-zurich`)

## Provenance

Content hash: 9598d326124a83f884bdf169221123d23e69b11f913b3cd89095f88098762105
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
